Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 296
Selected: 0
NCT IDTitle
NCT03848832Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT01461915Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
NCT04602936Solriamfetol in Binge Eating Disorder
NCT01610713An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT01696084Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
NCT02348606"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
NCT04425655Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
NCT07780968Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
NCT00693602Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma
NCT04794491An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy
NCT00670696A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel
NCT02806908Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
NCT00506974Enhancing Slow Wave Sleep With Sodium Oxybate
NCT00272948Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
NCT03533114A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension
NCT05629702ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
NCT04541082Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
NCT01943682Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
NCT05391724Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects
NCT06143839VYxeoS Liposomal Italian Observational Study iN the Real Practice
NCT07459634A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
NCT00793598CMX001 in Post-transplant Patients With BK Virus Viruria
NCT05651152A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants
NCT02091206A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
NCT03878927CPX-351+GO in Subjects 55 Years Old, or Older, With AML
NCT00710554A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
NCT04145531An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
NCT05229588Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
NCT05720494A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants
NCT01323569Abuse Potential of Sativex
NCT03825796CPX-351 Plus Enasidenib for Relapsed AML
NCT04176042Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea
NCT02439957A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
NCT02224560Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT03897127Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
NCT00942305Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
NCT03485729ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
NCT01424566A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
NCT02544763A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
NCT05868226PRE-ISPY Phase I/II Oncology Platform Program
NCT05099666Lurbinectedin + Doxorubicin In Leiomyosarcoma
NCT02525692Oral ONC201 in Adult Recurrent Glioblastoma
NCT06435429A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
NCT04721691Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT01964547A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
NCT05126433Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
NCT02271347An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
NCT05392374Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
NCT01643408A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
NCT04421456Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment